GN0M.DE vs. XGEN.DE
GN0M.DE (Global X Genomics & Biotechnology UCITS ETF) and XGEN.DE (Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C) are both Health & Biotech Equities funds - GN0M.DE tracks the Solactive Genomics while XGEN.DE tracks the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. Both are passively managed. Over the past 3 years, GN0M.DE returned -1.90%/yr vs 1.39%/yr for XGEN.DE. Their correlation of 0.85 suggests significant overlap in exposure. GN0M.DE charges 0.50%/yr vs 0.30%/yr for XGEN.DE.
Performance
GN0M.DE vs. XGEN.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GN0M.DE achieves a 12.99% return, which is significantly higher than XGEN.DE's -1.40% return.
GN0M.DE
- 1D
- 5.61%
- 1M
- 11.50%
- YTD
- 12.99%
- 6M
- 9.82%
- 1Y
- 55.73%
- 3Y*
- -1.90%
- 5Y*
- —
- 10Y*
- —
XGEN.DE
- 1D
- 3.92%
- 1M
- 5.33%
- YTD
- -1.40%
- 6M
- -3.45%
- 1Y
- 22.88%
- 3Y*
- 1.39%
- 5Y*
- —
- 10Y*
- —
GN0M.DE vs. XGEN.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
GN0M.DE Global X Genomics & Biotechnology UCITS ETF | 12.99% | 5.67% | -12.40% | -9.04% | -14.98% |
XGEN.DE Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | -1.40% | 7.38% | 2.95% | -5.84% | -9.98% |
Correlation
The correlation between GN0M.DE and XGEN.DE is 0.86, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.86 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.85 |
Correlation (All Time) Calculated using the full available price history since Jul 20, 2022 | 0.85 |
The correlation between GN0M.DE and XGEN.DE has been stable across timeframes, ranging from 0.85 to 0.86 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GN0M.DE vs. XGEN.DE — Risk / Return Rank
GN0M.DE
XGEN.DE
GN0M.DE vs. XGEN.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GN0M.DE | XGEN.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.78 | ||
| Sortino ratioReturn per unit of downside risk | +0.98 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.21 | +0.12 |
| Calmar ratioReturn relative to maximum drawdown | 3.32 | 1.49 | +1.84 |
| Martin ratioReturn relative to average drawdown | 8.35 | 3.61 | +4.74 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| GN0M.DE | XGEN.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.00 | 1.23 | +0.78 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.34 | -0.11 | -0.24 |
Drawdowns
GN0M.DE vs. XGEN.DE - Drawdown Comparison
The maximum GN0M.DE drawdown since its inception was -67.19%, which is greater than XGEN.DE's maximum drawdown of -37.58%. Use the drawdown chart below to compare losses from any high point for GN0M.DE and XGEN.DE.
Loading charts...
Drawdown Indicators
| GN0M.DE | XGEN.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.19% | -37.58% | -29.61% |
Max Drawdown (1Y)Largest decline over 1 year | -16.68% | -14.99% | -1.69% |
Max Drawdown (3Y)Largest decline over 3 years | -48.19% | -28.21% | -19.98% |
Current DrawdownCurrent decline from peak | -41.03% | -14.86% | -26.17% |
Average DrawdownAverage peak-to-trough decline | -43.13% | -19.44% | -23.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.65% | 6.19% | +0.46% |
Volatility
GN0M.DE vs. XGEN.DE - Volatility Comparison
Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) has a higher volatility of 8.15% compared to Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) at 6.48%. This indicates that GN0M.DE's price experiences larger fluctuations and is considered to be riskier than XGEN.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GN0M.DE | XGEN.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.15% | 6.48% | +1.67% |
Volatility (6M)Calculated over the trailing 6-month period | 19.69% | 13.73% | +5.96% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.68% | 18.19% | +9.49% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.49% | 18.66% | +12.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 31.49% | 18.66% | +12.83% |
GN0M.DE vs. XGEN.DE - Expense Ratio Comparison
GN0M.DE has a 0.50% expense ratio, which is higher than XGEN.DE's 0.30% expense ratio.
Dividends
GN0M.DE vs. XGEN.DE - Dividend Comparison
Neither GN0M.DE nor XGEN.DE has paid dividends to shareholders.
Frequently Asked Questions
GN0M.DE and XGEN.DE have a correlation of 0.86, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XGEN.DE is cheaper at 0.30% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XGEN.DE is cheaper with a 0.30% expense ratio, compared with 0.50% for GN0M.DE.
GN0M.DE tracks Solactive Genomics, while XGEN.DE tracks MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. They also come from different issuers: Global X and Xtrackers. Their fees differ too: 0.50% for GN0M.DE and 0.30% for XGEN.DE.
Find the right allocation for GN0M.DE and XGEN.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer